hela s3 Search Results


helas3 cells  (ATCC)
97
ATCC helas3 cells
Helas3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/HeLa+S3/pm34376057-30-19-21
Average 97 stars, based on 1 article reviews
helas3 cells - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
hela s3 cells  (CLS Cell Lines Service GmbH)
94
CLS Cell Lines Service GmbH hela s3 cells
Hela S3 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/HeLa+S3+Cells/bio_rxiv__64898__2026__03__13__711248-274-0-3
Average 94 stars, based on 1 article reviews
hela s3 cells - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
hela s3 cells  (ATCC)
96
ATCC hela s3 cells
Hela S3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/HeLa+S3%3B+Cervical+Adenocarcinoma%3B+Human/pm10729145-95-12-15
Average 96 stars, based on 1 article reviews
hela s3 cells - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
hela s3  (DSMZ)
94
DSMZ hela s3
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela S3, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/HELA-S3/pm12082631-166-11-14
Average 94 stars, based on 1 article reviews
hela s3 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
hela cell line  (BioResource International Inc)
90
BioResource International Inc hela cell line
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela Cell Line, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+cells/pmc11486946__41467_2024_53432_MOESM10_ESM-40-4-11
Average 90 stars, based on 1 article reviews
hela cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela-s3 cells  (Biovest Inc)
90
Biovest Inc hela-s3 cells
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela S3 Cells, supplied by Biovest Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+cells/pmc05890937-687-0-4
Average 90 stars, based on 1 article reviews
hela-s3 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela s3  (JCRB Cell Bank)
90
JCRB Cell Bank hela s3
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela S3, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+cells/pm27296359-43-1-11
Average 90 stars, based on 1 article reviews
hela s3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human cervical carcinoma cells (hela)  (BioWhittaker Molecular Applications)
90
BioWhittaker Molecular Applications human cervical carcinoma cells (hela)
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Human Cervical Carcinoma Cells (Hela), supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+cells/pm37641805-35-5-18
Average 90 stars, based on 1 article reviews
human cervical carcinoma cells (hela) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela s3 cells  (Helmholtz Zentrum fur Infektionsforschung GmbH)
90
Helmholtz Zentrum fur Infektionsforschung GmbH hela s3 cells
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela S3 Cells, supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+cells/pm28781166-256-0-9
Average 90 stars, based on 1 article reviews
hela s3 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
wild-type hela s3 cells  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures wild-type hela s3 cells
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Wild Type Hela S3 Cells, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/wild+type+hela+s3+cells/pmc11166877-193-0-6
Average 90 stars, based on 1 article reviews
wild-type hela s3 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
affinity-purified sp1 overexpressed in hela s3 cells  (Promega)
90
Promega affinity-purified sp1 overexpressed in hela s3 cells
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Affinity Purified Sp1 Overexpressed In Hela S3 Cells, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/affinity+purified+sp1+overexpressed+hela+s3+cells++sp1/pm09006935-229-20-27
Average 90 stars, based on 1 article reviews
affinity-purified sp1 overexpressed in hela s3 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hela s3 whole-cell lysate  (ESI Source Solutions LLC)
90
ESI Source Solutions LLC hela s3 whole-cell lysate
Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in <t>HeLa</t> <t>S3</t> cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin
Hela S3 Whole Cell Lysate, supplied by ESI Source Solutions LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hela+s3/hela+s3+whole+cell+lysate/pmc04541035-194-12-25
Average 90 stars, based on 1 article reviews
hela s3 whole-cell lysate - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in HeLa S3 cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin

Journal: Oncogene

Article Title: Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

doi: 10.1038/sj.onc.1205412

Figure Lengend Snippet: Figure 1 Reduction of PLK1 mRNA in vitro. (a) Relative positioning of the predicted hybridization sites of the 26 tested PLK1 ASOs. Sequences of all ASOs are available upon request. Arrows indicate positions of the potent ASOs P12 and P13. (b) Northern blot analysis of PLK1 mRNA in MDA-MB-435 cells 24 h after ASO treatment. HSV-ASO served as negative control. To ascertain uniformity of loading the membrane was reprobed with human b-actin and G3PDH. Per cent inhibition was calculated by comparison with standardized PLK1 mRNA levels of cells grown in the absence of ASOs. PLK1 mRNA expression in HeLa S3 cells (c) and A549 cells (d) 24 h after ASO application. Membranes were reprobed with human b-actin

Article Snippet: Tumor cell lines MDA-MB-435 and A549 were obtained from CLS (Heidelberg), HeLa S3 from DSMZ (Braunschweig) and cultured according to their instructions with slight modi®cations.

Techniques: In Vitro, Hybridization, Northern Blot, Negative Control, Membrane, Inhibition, Comparison, Expressing

Figure 2 Inhibition of PLK1 protein expression and kinase activity by PLK1-speci®c ASOs in cancer cells. Control cells were incubated with OPTIMEM. HSV-ASO served as negative control. Per cent inhibition was calculated by comparison with PLK1 protein levels in cells grown in the absence of ASOs. (a) Western blot analysis of PLK1 protein in MDA-MB-435 cells 48 h after ASO treatment. Indicated are the signals for PLK1 and actin in both autoradiographs. Actin served as control for equal loading (upper panel). Quanti®cation of PLK1 protein levels after normalization to actin was performed using a Kodak gel documentation system (1D 3.5). Mean values of at least 3 independent experiments with standard deviation are shown (lower panel). Quanti®cation of PLK1 protein in HeLa S3 cells (b) and A549 cells (c) after normalization to actin. PLK1 protein correlated to the concentration of ASO P12 in HeLa S3 cells (d) and in MDA-MB-435 cells (e). PLK1 immunoprecipitated from ASO treated cells phosphorylated casein to a lower extent compared to PLK1 from control cells (upper panel). Coomassie staining served as control for equal loading of substrate (middle panel). Equal amounts of PLK1 were subjected to the enzymatic assay (lower panel) (f)

Journal: Oncogene

Article Title: Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

doi: 10.1038/sj.onc.1205412

Figure Lengend Snippet: Figure 2 Inhibition of PLK1 protein expression and kinase activity by PLK1-speci®c ASOs in cancer cells. Control cells were incubated with OPTIMEM. HSV-ASO served as negative control. Per cent inhibition was calculated by comparison with PLK1 protein levels in cells grown in the absence of ASOs. (a) Western blot analysis of PLK1 protein in MDA-MB-435 cells 48 h after ASO treatment. Indicated are the signals for PLK1 and actin in both autoradiographs. Actin served as control for equal loading (upper panel). Quanti®cation of PLK1 protein levels after normalization to actin was performed using a Kodak gel documentation system (1D 3.5). Mean values of at least 3 independent experiments with standard deviation are shown (lower panel). Quanti®cation of PLK1 protein in HeLa S3 cells (b) and A549 cells (c) after normalization to actin. PLK1 protein correlated to the concentration of ASO P12 in HeLa S3 cells (d) and in MDA-MB-435 cells (e). PLK1 immunoprecipitated from ASO treated cells phosphorylated casein to a lower extent compared to PLK1 from control cells (upper panel). Coomassie staining served as control for equal loading of substrate (middle panel). Equal amounts of PLK1 were subjected to the enzymatic assay (lower panel) (f)

Article Snippet: Tumor cell lines MDA-MB-435 and A549 were obtained from CLS (Heidelberg), HeLa S3 from DSMZ (Braunschweig) and cultured according to their instructions with slight modi®cations.

Techniques: Inhibition, Expressing, Activity Assay, Control, Incubation, Negative Control, Comparison, Western Blot, Standard Deviation, Concentration Assay, Immunoprecipitation, Staining, Enzymatic Assay

Figure 3 Antiproliferative eects of PLK1 antisense inhibition in cancer cells. Control cells were incubated only with OPTIMEM. HSV-ASO served as a control. Percent inhibition was calculated by comparison to the number of cells treated with DOTAP grown in the absence of ASOs. (a) Growth inhibition of MDA-MB-435 cells treated with ASOs at a concentration of 250 nM over a period of 2 days. Growth inhibition of HeLa S3 (b) and A549 cells (c) over a period of 3 days. Dose-dependent reduction of MDA-MB-435 cells (d) and HeLa S3 cells (e) after ASO treatment. Mean values of at least three independent experiments with standard deviation are shown

Journal: Oncogene

Article Title: Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

doi: 10.1038/sj.onc.1205412

Figure Lengend Snippet: Figure 3 Antiproliferative eects of PLK1 antisense inhibition in cancer cells. Control cells were incubated only with OPTIMEM. HSV-ASO served as a control. Percent inhibition was calculated by comparison to the number of cells treated with DOTAP grown in the absence of ASOs. (a) Growth inhibition of MDA-MB-435 cells treated with ASOs at a concentration of 250 nM over a period of 2 days. Growth inhibition of HeLa S3 (b) and A549 cells (c) over a period of 3 days. Dose-dependent reduction of MDA-MB-435 cells (d) and HeLa S3 cells (e) after ASO treatment. Mean values of at least three independent experiments with standard deviation are shown

Article Snippet: Tumor cell lines MDA-MB-435 and A549 were obtained from CLS (Heidelberg), HeLa S3 from DSMZ (Braunschweig) and cultured according to their instructions with slight modi®cations.

Techniques: Inhibition, Control, Incubation, Comparison, Concentration Assay, Standard Deviation